No excess surgical blood loss in patients with acquired type 2A von Willebrand disease

By Mikkelsen Martin Majlund   Fenger-Eriksen Christian   Johnsen Søøren Paaske   Christensen Thomas Decker   Søørensen Benny  

Scandinavian Cardiovascular Journal, Vol. 45, Iss. 2, 2011-04 ,pp. : 120-126

Informa Healthcare

Access to resources Recommend Favorite

BINDING OF THE VON WILLEBRAND FACTOR A1 DOMAIN TO HISTONE - I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome

By Ward C.M.   Tetaz T.J.   Andrews R.K.   Berndt M.C.  

Thrombosis Research, Vol. 86, Iss. 6, 1997-06 ,pp. : 469-477

Elsevier

Access to resources Recommend Favorite

The role of osmoregulation in the pathophysiology and management of Severe Ovarian Hyperstimulation Syndrome

By Evbuomwan Isaac  

Human Fertility, Vol. 16, Iss. 3, 2013-09 ,pp. : 162-167

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiology, Diagnosis and Clinical Management of Hepatorenal Syndrome: From Classic to New Drugs

By  

Current Vascular Pharmacology, Vol. 12, Iss. 1, 2014-01 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside

By  

Current Vascular Pharmacology, Vol. 12, Iss. 4, 2014-01 ,pp. : 565-571

Bentham Science Publishers

Access to resources Recommend Favorite